(Total Views: 169)
Posted On: 04/01/2022 3:35:56 PM
Post# of 145213

$ALT News Article - Altimmune Announces Initiation of 48-week Phase 2 MOMENTUM Trial of Pemvidutide in Obesity https://marketwirenews.com/news-releases/alti...99713.html


My Twitter: WhyteStocks